Predictive factors in patients with EGFR mutationnegative nonsmall cell lung cancer treated with erlotinib

Publisher： Spandidos Publications

E-ISSN： 1792-1082|8|6|2699-2704

ISSN： 1792-1074

Source： Oncology Letters, Vol.8, Iss.6, 2014-01, pp. : 2699-2704

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib

By                      

Experimental and Therapeutic Medicine, Vol. 2, Iss. 4, 2011-01 ,pp. : 685-693

Spandidos Publications

Access to resources Recommend Favorite

Polymorphisms in intron 1 of the EGFR gene in nonsmall cell lung cancer patients

By                              

Experimental and Therapeutic Medicine, Vol. 4, Iss. 5, 2012-01 ,pp. : 785-789

Spandidos Publications

Access to resources Recommend Favorite

Prognostic Factors for the Survival of Surgically Treated Patients for Non-Small Cell Lung Cancer

By Fernandes Oswaldo J.C.B.   Almgren Stig-olof   Thaning Lars   Filbey Derek   Helsing Martin   Karlsson Mats   Magnusson Anders   Souza Domingos  

Acta Oncologica, Vol. 42, Iss. 4, 2003-01 ,pp. : 338-341

Informa Healthcare

Access to resources Recommend Favorite

Prognostic and predictive values of pERK1/2 and pAkt-1 expression in non-small cell lung cancer patients treated with adjuvant chemotherapy

By Shi Yan  

Tumor Biology, Vol. 32, Iss. 2, 2011-04 ,pp. : 381-390

Springer Publishing Company

Access to resources Recommend Favorite

Observational study on the efficacy and safety of erlotinib in patients with non-small cell lung cancer

By                                              

Oncology Letters, Vol. 5, Iss. 2, 2013-01 ,pp. : 435-439

Spandidos Publications

Access to resources Recommend Favorite